What We Do
SPARK Impact is one of the most active investors in the UK. Our focus is building world-class businesses that offer solutions to some of the global challenges that we face . . . Learn more
Portfolio
Here are some of our portfolio companies . . . Learn more
Contact Us
Interested in what we do?
Contact us today for more information . . . Learn more
A pioneering diagnostic device identifies more abnormal cells on the cervix than standard colposcopy, according to data published in two European clinical papers. ZedScan is a portable, handheld device which uses Electrical Impedance Spectroscopy (EIS) technology to detect dysplasia and cancer of the…
New source of capital for company as pipeline develops Liverpool, UK - June 12 2017: Videregen Limited, a clinical stage regenerative medicine company developing personalised organ replacements, is pleased to announce that it has become a member of the UK Social…
Press Release - 24th May 2017 Further Isle of Man Enterprise Development Scheme (EDS) investments have continued to complete in the last month, SPARK Impact Limited (SPARK) has confirmed. It follow’s April’s announcement that several agreements had been reached and…
NEW YORK (GenomeWeb) – British molecular diagnostics company Cytox plans to make a molecular test for the early-stage diagnosis of Alzheimer's disease available in the US by year end. The Oxford-based firm is also in discussions with multiple pharmaceutical and…
Who we work with
